<DOC>
	<DOC>NCT02202980</DOC>
	<brief_summary>This study will evaluate the antiviral efficacy, safety, and tolerability of combination therapy with oral regimens for the treatment of chronic hepatitis C virus (HCV) infection.</brief_summary>
	<brief_title>Efficacy and Safety of Oral Regimens for the Treatment of Chronic HCV Infection</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Hepatitis C, Chronic</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<criteria>Willing and able to provide written informed consent Chronic HCV infection Cirrhosis determination (liver biopsy may be required) Screening laboratory values within specified limits Males and females of childbearing potential who engage in heterosexual intercourse must agree to use protocol specified method(s) of contraception Specific genotype, prior medical history, or concurrent disease as required by the specific study group History of clinically significant illness or any other medical disorder that may interfere with subject treatment, assessment or compliance with the protocol Pregnant or nursing female, or male with pregnant female partner Clinical hepatic decompensation (ie, ascites, encephalopathy or variceal hemorrhage) Use of any prohibited concomitant medications</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>